XML 92 R72.htm IDEA: XBRL DOCUMENT v3.25.2
Note 14 - Share Based Payments (Details Textual)
$ / shares in Units, $ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 27, 2024
CAD ($)
$ / shares
Sep. 09, 2024
CAD ($)
Aug. 28, 2024
CAD ($)
$ / shares
Feb. 12, 2024
CAD ($)
$ / shares
Jan. 15, 2024
CAD ($)
$ / shares
Aug. 11, 2023
CAD ($)
$ / shares
Nov. 15, 2022
USD ($)
$ / shares
Nov. 15, 2022
USD ($)
$ / shares
Dec. 20, 2024
Dec. 31, 2024
CAD ($)
$ / shares
Dec. 31, 2023
CAD ($)
$ / shares
Dec. 31, 2022
CAD ($)
$ / shares
Statement Line Items [Line Items]                        
Number of share options granted in share-based payment arrangement     250,000 753,923 25,000         1,028,923 104,080 115,291
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares     $ 3.28 $ 3.24 $ 2         $ 3.22 $ 8.96 $ 18.64
Weighted average fair value at measurement date, share options granted     $ 418,000 $ 1,377,000 $ 29,000           $ 577,000  
Risk free interest rate, share options granted     3.31% 4.15% 4.15%              
Option life, share options granted     2 3 3              
Expected volatility, share options granted     93.74% 84.64% 86.97%              
Expected dividend, share options granted     $ 0 $ 0 $ 0           $ 0  
Weighted average share price, share options granted (in CAD per share) | $ / shares     $ 3.28 $ 3.24 $ 2              
Number of other equity instruments exercised or vested in share-based payment arrangement                     0  
Proceeds from exercise of warrants                   $ 0 $ 0 $ 807,000
Number of other equity instruments expired in share-based payment arrangement                     245,257  
Bottom of range [member]                        
Statement Line Items [Line Items]                        
Risk free interest rate, share options granted                     3.37%  
Option life, share options granted                     4  
Expected volatility, share options granted                     82.51%  
Weighted average share price, share options granted (in CAD per share) | $ / shares                     $ 3.92  
Exercise price of outstanding share options (in CAD per share) | $ / shares                   $ 2 $ 9.5  
Top of range [member]                        
Statement Line Items [Line Items]                        
Risk free interest rate, share options granted                     4.15%  
Option life, share options granted                     5  
Expected volatility, share options granted                     85.41%  
Weighted average share price, share options granted (in CAD per share) | $ / shares                     $ 9.6  
Exercise price of outstanding share options (in CAD per share) | $ / shares                   $ 24.84 $ 29.16  
Restricted share units [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement       26,235           26,235 124,968 12,722
Expense from share-based payment transactions                   $ 338,000 $ 641,000 $ 297,000
Number of other equity instruments exercised or vested in share-based payment arrangement                   130,414 764 7,277
Number of other equity instruments expired in share-based payment arrangement                   (0) 4,750 1,801
Deferred share units [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement   33,891               33,891 104,545 17,868
Weighted average fair value at measurement date, other equity instruments granted   $ 96,000                    
Expense from share-based payment transactions                   $ 218,000 $ 586,000 $ 189,000
Number of other equity instruments exercised or vested in share-based payment arrangement                   18,568 (0) 3,123
Number of other equity instruments expired in share-based payment arrangement                   12,279 9,332 (0)
Options [member]                        
Statement Line Items [Line Items]                        
Expense from share-based payment transactions                   $ 1,212,000 $ 513,000 $ 505,000
Performance share units [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement                   0 0 4,514
Expense from share-based payment transactions                   $ 0 $ 79,000 $ 291,000
Number of other equity instruments exercised or vested in share-based payment arrangement                   2,083 (0) 7,118
Number of other equity instruments expired in share-based payment arrangement                   6,424 7,465 3,299
Warrants issued in November 15, 2022 Offering [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement             586,250 586,250        
Weighted average fair value at measurement date, other equity instruments granted             $ 2,087 $ 2,087        
Risk free interest rate, other equity instruments granted             4.172% 4.172%        
Expected volatility, other equity instruments granted             62.89% 62.89%        
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares             $ 9.4          
Exercise price, other equity instruments granted (in dollars per share) | $ / shares               $ 12.4        
November 15, 2022 Offering, Broker Warrant Units [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement             34,538 34,538        
Weighted average fair value at measurement date, other equity instruments granted             $ 325 $ 325        
CAD warrants [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement                   1,136,364 5,111,364  
Number of other equity instruments exercised or vested in share-based payment arrangement                       52,636
Proceeds from exercise of warrants                       $ 807
Number of other equity instruments expired in share-based payment arrangement                     245,257 20,803
USD warrants [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement                     2,699,014 620,788
August 11, 2023 warrants [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement           4,886,364            
Weighted average fair value at measurement date, other equity instruments granted           $ 6,321,000            
Risk free interest rate, other equity instruments granted           4.68%            
Expected volatility, other equity instruments granted           66.07%            
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares           $ 4.76            
Other equity instruments life, share options granted           2            
Expected dividend, other equity instruments granted           $ 0            
August 11, 2023 Broker Warrants [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement           225,000            
Weighted average fair value at measurement date, other equity instruments granted           $ 990,000            
The 2028 warrants [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement                     2,699,014  
Class of warrant or right, acceleration clause, stock price trigger (in CAD per share) | $ / shares $ 3.4                 $ 4.8    
The 2027 warrants [member]                        
Statement Line Items [Line Items]                        
Number of other equity instruments granted in share-based payment arrangement 1,136,364                      
Weighted average fair value at measurement date, other equity instruments granted $ 1,221,000                      
Long term incentive plan [member]                        
Statement Line Items [Line Items]                        
Number of instruments granted in share-based payment arrangement                 1,825,000      
Employee share purchase plan [member]                        
Statement Line Items [Line Items]                        
Number of instruments granted in share-based payment arrangement                   250,000